Failure to thrive in children with tubulopathies

Giulio Rivetti1, Francesco Emma2, Faidra Veligratli3

  • 1Department of Woman, Child and of General and Specialized Surgery, Università Degli Studi Della Campania "Luigi Vanvitelli", Via Luigi De Crecchio 2, 80138, Naples, Italy.

Insights

Failure to thrive (FTT) in children with kidney tubulopathies stems from impaired nutrient and electrolyte balance. This review covers how kidney dysfunction causes growth problems and how to manage these complex pediatric cases.

Area of Science:

  • Pediatric Nephrology
  • Growth Disorders
  • Renal Physiology

Background:

  • Failure to thrive (FTT) is a significant clinical issue in pediatric tubulopathies.
  • Kidney tubule dysfunction affects solute, electrolyte, and acid-base homeostasis.
  • These imbalances disrupt normal growth via renal and systemic pathways.

Purpose of the Study:

  • To review the current evidence on FTT in pediatric tubulopathies.
  • To elucidate the pathophysiological mechanisms linking tubulopathies to impaired growth.
  • To outline the clinical presentation and management strategies for FTT in this population.

Main Methods:

  • Literature review of pathophysiological mechanisms.
  • Analysis of clinical presentation data.
  • Summary of current management guidelines.

Main Results:

  • Defective tubular transport underlies FTT in pediatric tubulopathies.
  • Impaired handling of solutes, electrolytes, and acid-base balance are key contributors.
  • Both renal-specific and systemic effects impede growth.

Conclusions:

  • Understanding the pathophysiology of FTT in pediatric tubulopathies is crucial.
  • Early recognition of clinical signs aids timely intervention.
  • Comprehensive management strategies are essential for optimizing growth outcomes.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
684
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.1K